Jennison Associates LLC Charles River Laboratories International, Inc. Transaction History

Jennison Associates LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 06, 2020	SELL	$118.84 - $189.72 $495,443 - $790,942	-4,169 Closed	0 $0
Q1 2020 May 06, 2020	SELL	$98.9 - $178.34 $506,961 - $914,170	-5,126 Reduced 55.15%	4,169 $526,000
Q2 2019 Aug 06, 2019	SELL	$123.4 - $148.55 $24,063 - $28,967	-195 Reduced 2.05%	9,295 $0
Q1 2019 May 10, 2019	BUY	$104.82 - $146.73 $994,741 - $1.39 Million	9,490 New	9,490 $1.38 Million
Q4 2017 Jan 25, 2018	SELL	$100.43 - $118.09 $1.73 Million - $2.04 Million	-17,241 Closed	0 $0
Q3 2017 Nov 03, 2017	BUY	$96.72 - $109.26 $1.67 Million - $1.88 Million	17,241	17,241 $1.86 Million

708

53.9M

122K

239K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.67B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.